IDO-BASED IMMUNE CHECKPOINT BLOCKADE FOR PEDIATRIC BRAIN TUMORS: PRECLINICAL DATA AND CLINICAL TRIAL DESIGN

被引：0
|
作者：
Johnson, Theodore [1 ]
Li, Minghui [1 ]
Gamble, Denise [1 ]
Macdonald, Tobey [1 ]
Munn, David [1 ]
机构：
[1] Georgia Regents Univ, Augusta, GA USA
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
756
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [21] A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
    Rappaport, Amy R.
    Kyi, Chrisann
    Lane, Monica
    Hart, Meghan G.
    Johnson, Melissa L.
    Henick, Brian S.
    Liao, Chih-Yi
    Mahipal, Amit
    Shergill, Ardaman
    Spira, Alexander I.
    Goldman, Jonathan W.
    Scallan, Ciaran D.
    Schenk, Desiree
    Palmer, Christine D.
    Davis, Matthew J.
    Kounlavouth, Sonia
    Kemp, Lindsey
    Yang, Aaron
    Li, Yaojun John
    Likes, Molly
    Shen, Annie
    Boucher, Gregory R.
    Egorova, Milana
    Veres, Robert L.
    Espinosa, J. Aaron
    Jaroslavsky, Jason R.
    Tardif, Lauren D. Kraemer
    Acrebuche, Lindsey
    Puccia, Christopher
    Sousa, Leiliane
    Zhou, Rita
    Bae, Kyounghwa
    Hecht, J. Randolph
    Carbone, David P.
    Johnson, Benny
    Allen, Andrew
    Ferguson, Andrew R.
    Jooss, Karin
    NATURE MEDICINE, 2024, 30 (04) : 1013 - 1022
  • [22] Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials
    Jiang, Minhan
    Fiering, Steven
    Shao, Qi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Pediatric brain tumors in Japan based on the data of the brain tumor registry of Japan (BTRJ)
    Shibui, S.
    Narita, Y.
    Miyakita, Y.
    Nomura, K.
    NEURO-ONCOLOGY, 2007, 9 (02) : 198 - 198
  • [24] Facial palsy induced by immune checkpoint blockade: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data
    Zhu, Jianhong
    Li, Jianfang
    Zheng, Yayuan
    Gao, Siyuan
    He, Zhichao
    Qiu, Kaifeng
    Yu, Xiaoxia
    Wu, Junyan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [25] Exploring the association of smoking status with clinical outcomes in patients with mPDAC treated on a clinical trial of maintenance niraparib plus immune checkpoint blockade
    Rathore, Srishti
    Reiss, Kim Anna
    Teitelbaum, Ursina R.
    Chapin, William Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] CA-4948 (emavusertib) improves treatment response of preclinical metastatic brain melanoma to anti-PD-1 immune checkpoint blockade
    von Roemeling, Christina A.
    Doonan, Bently P.
    Acevedo, Amanda M.
    Patel, Jeet A.
    Carpenter, Savannah L.
    Bhatia, Alisha
    von Roemeling, Reinhard W.
    Hoffman, Jamison
    Lane, Maureen
    Mitchell, Duane A.
    CANCER RESEARCH, 2024, 84 (06)
  • [27] The emerging landscape of immune checkpoint inhibitor based clinical trials in adults with advanced rare tumors
    Mittra, Arjun
    Takebe, Naoko
    Florou, Vaia
    Chen, Alice P.
    Naqash, Abdul Rafeh
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (07) : 1935 - 1939
  • [28] Predicting clinical trial success for Clostridium difficile infections based on preclinical data
    Li, Fangzhou
    Youn, Jason
    Millsop, Christian
    Tagkopoulos, Ilias
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2024, 7
  • [29] Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial
    Dong, Liang
    Cao, Zhi
    Chen, Meixia
    Liu, Yang
    Ma, Xinran
    Lu, Yuting
    Zhang, Yan
    Feng, Kaichao
    Zhang, Yang
    Meng, Zhenzhen
    Yang, Qingming
    Wang, Yao
    Wu, Zhiqiang
    Han, Weidong
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [30] Identification of novel modulators of response to immune checkpoint blockade in lung cancer patients through the marrying of clinical and genomic data
    Stephens, Phil
    CANCER RESEARCH, 2017, 77
12345